MGI Tech (SHA:688114) agreed to sell U.S.-based subsidiary Complete Genomics for $50 million while amending the licensing terms with Swiss firm Swiss Rockets.
The amendments add licensing terms for StandardMPS sequencing technology-related products, according to a Tuesday filing with the Shanghai bourse.
Swiss Rockets will also need to pay licensing fees for subsequent sales of StandardMPS sequencing technology-related products.
Shares of the genome sequencing machine manufacturer were up 2% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments